Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Mar 22:12:129-131.
doi: 10.2147/MDER.S202581. eCollection 2019.

Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study"

Sabine Ettinger  1 , Michal Stanak  1 , Piotr Szymański  2 , Claudia Wild  1 , Romana Tandara Haček  3 , Darija Erčević  3 , Renata Grenković  3 , Gregor Goetz  1 , Mirjana Huić  3
Affiliations
Comment

Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study"

Sabine Ettinger et al. Med Devices (Auckl). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this communication.

Comment on

References

    1. Sperzel J, Staudacher I, Goeing O, et al. Critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study. Med Devices (Auckl) 2018;11:201–204. - PMC - PubMed
    1. European Network for Health Technology Assessment (EUnetHTA) Guideline; Internal validity of non-randomised studies (NRS) on interventions. Jul, 2015. [Accessed December 12, 2018]. Available from: https://www.eunethta.eu/wp-content/uploads/2018/01/Internal-validity-of-....
    1. Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable cardioverter–defibrillator after myocardial infarction. N Engl J Med. 2018;379(13):1205–1215. - PMC - PubMed
    1. Chiarolla E, Orso M, Goetz G, Stanak M, Wild C, Jefferson T. Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. AGENAS & LBI-HTA; 2018. [Accessed January 15, 2019]. Update. Available from: http://eprints.hta.lbg.ac.at/1186/
    1. Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62(21):2000–2007. - PubMed

LinkOut - more resources